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A B S T R A C T
Purpose: To describe the neurophysiological and clinical features of Nodding Syndrome (NS) in South
Sudan.
Methods: The study was performed at the Epilepsy Service of ‘‘Usratuna’’ sited in Juba, South Sudan. The
clinical history of each subject was collected along with an EEG tracing.
Results: Twenty-one children (10 females) were diagnosed with NS. Fifteen (72%) children were
classiﬁed as Probable NS and six (28%) as Conﬁrmed NS. They ranged in age between 6 and 14 years, and
age at seizure onset ranged from 5 to 12 years. All the subjects presented with intellectual disability
which was mild in severity in 12 (57%) cases, moderate in seven (33%) cases and severe in two (10%)
cases. Interictal EEG was abnormal in 20 subjects. In 18 (85%) subjects, the EEG showed 2–3.5 Hz spike-
and-wave discharges often intermingled with sharp waves. Intermittent light stimulation was normal. In
12 (57%) children, interictal abnormalities were activated by hyperventilation. Ictal EEG was obtained in
three patients. In all ictal EEGs head nodding episodes came in clusters during hyperventilation. None of
the patients achieved good seizure control even if all of them received antiepileptic treatment
(carbamazepine alone [43%] or in association with phenobarbitone or phenytoin).
Conclusion: This study conﬁrms that NS is an encephalopathy and intellectual disabilities are partially
independent of seizure frequency and EEG pathological activity. Based on interictal and ictal EEG
patterns and on the experience of other researchers, valproic acid would seem to be the ﬁrst-choice
antiepileptic drug. NS in South Sudan presents with clinical and neurophysiological features which are
similar to those described in northern Uganda and more severe than in Tanzania.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Nodding Syndrome (NS) is a neurological disorder ﬁrst
documented in southern Tanzania in the 1960s [1], in southern
regions of South Sudan in the 1990s [2] and in northern Uganda in
2007 [3]. Typical signs of NS include the occurrence of repetitive
head nodding, variably associated with different types of seizures,
neurologic and intellectual disability, delayed puberty and growth
delay in children (age range generally between 5 and 15 years)* Corresponding author at: Neuropsychiatry and Neurorehabilitation Unit,
Scientiﬁc Institute, IRCCS Eugenio Medea, Via D. L. Monza 20, 23842 Bosisio Parini,
Lecco, Italy. Tel.: +39 031877111; fax: +39 031877499.
E-mail address: renato.borgatti@bp.lnf.it (R. Borgatti).
http://dx.doi.org/10.1016/j.seizure.2015.07.006
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights re[4]. At onset, the syndrome is characterized by frequent head-
nodding episodes, occurring several times a week to many times a
day, often triggered by eating or cold weather and accompanied by
intellectual disability [4]. The head drops repeatedly toward the
chest in cycles of 5–20 nods/min for several minutes. Head
nodding episodes may be accompanied by automatisms, staring
and unresponsiveness [5]. As revealed by electroencephalogram
(EEG) recordings [6–8], [3] videography, electromyography and
electrocardiography, nodding episodes are epileptic manifesta-
tions; however their nature is still controversial (atonic seizures or
atypical absences) [3,7,8]. The severity of the disease was
associated with more severe EEG ﬁndings, with progressively
more abnormal background activity to diffuse sub-continuous
non-reacting theta–delta activity and loss of normal cerebral
electrical architecture [3,6–8]. Response to different antiepilepticserved.
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occasionally yet not consistently helpful [8,9].
Owing to the devastating effects of this disorder on families and
communities (loss of the ability to eat, risk of burns and drowning,
dropping out of school), local authorities and national govern-
ments requested the assistance of the World Health Organization
(WHO), the US Centers for Disease Control and Prevention (CDC),
and other agencies [4]. The syndrome progressively worsens and
often death occurs even if its mortality rate is unclear [9,10]. To
date the causes of NS are unknown. Associations with onchocerci-
asis and nutritional deﬁciencies or unidentiﬁed toxin exposure
have been consistent features, but no deﬁnitive underlying cause
has been identiﬁed [9,10]. Thousands (approximately 3000–8000)
of cases have been reported only in geographic and familial
clusterings from southern Tanzania, northern Uganda and South
Sudan, suggesting a genetic etiology for the syndrome. For these
reasons, studies comparing populations coming from different
countries may be of great interest [7,11].
The aim of this study was to better characterize the clinical and
neurophysiological spectrum of NS describing 21 children
(10 females) from South Sudan studied from October 2012 to
December 2013.
2. Methods
This study was performed at the Epilepsy Service sited in Juba,
the capital of South Sudan, of ‘‘Usratuna’’ Health and Rehabilitation
Center started and promoted by the Italian Non-Governmental
Organization ‘‘OVCI La Nostra Famiglia’’, specialized in the
diagnosis and treatment of epilepsy. It is the only service
exclusively dedicated to this pathology nationwide. The Center
has been operating since the beginning of the 1980s and has
become a reference point for this pathology attracting patients
from Juba and neighboring areas. The daily clinical routine (more
than 40 patients a day and about 2200 patients a year) is managed
by two clinical ofﬁcers helped by a nurse speciﬁcally trained in the
diagnosis and treatment of epilepsy. Two Italian child neurologists
take turns every year to supervise the clinical activity on-site and
provide training and education. The two clinical ofﬁcers are native
speakers of South Sudanese and have a good command of English.
This has helped the two Italian neurologists in their training
activity and in monitoring the clinical activity on-site. At the same
time, however, it must be kept in mind that clinical ofﬁcers do not
receive the same training as medical doctors or neurologists. To
facilitate the visit and enable standardized data collection for every
patient attending the Center, a detailed questionnaire was
developed (see File S1 and File S2) in order to collect information
such as the patient’s full name, sex and age, age at ﬁrst episode,
seizure type and frequency, previous drug treatment (if any). In
addition, data were collected about the presence, if any, of epilepsy
in the family. All subjects receive a neurological examination and
information about their daily activities (level of education,
behavior, social interaction, etc.) is collected to deﬁne the severity
of their intellectual disability. Severe intellectual disability is
deﬁned as a signiﬁcant impairment in daily living activities (eating,
dressing, personal care, etc.). Patients are seen once a month or
once every 2 months; the course of epilepsy (improvement,
stabilization or worsening) is evaluated and antiepileptic treat-
ment is conﬁrmed or changed. Selected cases (such as NS patients)
undergo an EEG during wakefulness (since October 2012). Each
tracing is sent to Italy for interpretation, reporting and therapeutic
recommendations. These exams and testing were performed on
our NS patients from October 2012 to December 2013. A clinical
follow-up was obtained in most cases.
EEGs were performed on all 21 subjects using a portable
machine (MICROMED, BRAIN QUIK System Plus ANDYEEG25 class 1). A standard 10–20 montage (STANDARD MICROMED
18 leads: four inner right, four outer right, two median Fz-Cz and
Cz-Pz, four inner left and four outer left) was used.
All clinical data of NS patients collected during daily routine at
Usratuna Center (see supporting information) were entered
anonymously into an ‘‘Excel’’ database, that was made available
to Italian researchers along with EEG tracings. No informed
consent was obtained because the analysis was carried out on
pseudo-anonymized data. The Italian researchers who analyses the
data and wrote the paper were blind to the patients’ identities
which could only be traced by looking into the ﬁles at ‘‘Usratuna’’
Health and Rehabilitation Center. The ﬁles were accessible only to
the two clinical ofﬁcers, living in Juba.
In order to compare the data collected with reports from
Uganda and Tanzania, a complete review of the literature was
made and cases reported were collected and summarized (see
Table 1).
The diagnosis of NS was made according to the classiﬁcation
criteria proposed at the International Conference held in Kampala
(2012) [12].
The study methodology was approved by the local Ethics
Committee of Scientiﬁc Institute Eugenio Medea on May 12, 2015.
3. Results
Twenty-one South Sudanese subjects (10 females) were
diagnosed with NS. They came from seven different regions of
South Sudan: Rumbek, Mundri, Maridi, Yambio, Wau, Lui and Juba
(for detailed information on NS Patients, see Table 2). Three cases
presented with a family history of NS (cases 16 and 18 are siblings
(brother and sister); case 1 has two siblings, one female and one
male, not yet included in this series). Follow-up evaluations ranged
from 6 month to 6 years (mean 3 years and 3 months).
Fifteen children (72%) were classiﬁed as ‘‘Probable NS’’ as they
satisﬁed the major and minor criteria (seizure onset, nodding
seizures, intellectual disability, and other seizures types), while six
children (28%) were classiﬁed as ‘‘Conﬁrmed NS’’ since a
documented nodding episode was reported. No patient was
deﬁned as ‘‘Suspected NS’’. According to the classiﬁcation proposed
by Winkler et al. [11], all the patients presented with ‘‘Head
Nodding plus (HN plus), with other seizure types’’. Fifteen subjects
displayed one additional type of seizure (11 subjects: focal
seizures, three subjects: focal seizures with secondary generaliza-
tion, one subject: generalized seizures), while six subjects had two
other types of seizures (both focal and generalized seizures).
At the last visit, the patients’ age ranged between 6 and
14 years, while seizure onset was between 5 and 12 years.
Interictal EEG (see two examples in Figs. 1 and 2) was abnormal
in all the patients but one (patient n. 18). The background activity
showed 4–7 rhythms in 17 patients. This abnormal activity was
diffuse in 12 patients, non-reactive to eye opening in seven of
them, and distributed over the fronto-centro-temporal and
midline regions in other ﬁve patients. The background activity
revealed diffuse alpha rhythms in two patients, while it was
normal in one patient. In 18 children (85%), the EEG showed
bilateral epileptiform abnormalities: 2–3.5 Hz spike and wave
discharges often intermingled with sharp waves. The epileptiform
abnormalities were diffuse in one patient and distributed over the
fronto-temporal or fronto-centro-temporal and midline regions in
15 cases, and over the centro-parieto-temporal regions in two
cases. In addition, focal sharp-waves – more frequently occurring
over temporal regions – were recorded in ﬁve patients. Response to
intermittent light stimulation (ILS) was normal in all the subjects.
In 12 patients (57%), interictal epileptiform abnormalities were
activated by hyperventilation.
Table 1










Clinical features AEDs and Response
to therapy
Sudan Our Series 18 Probable
NS
21 5–12 yrs 100% MR: 21/21 PB, CBZ, PHT
3 Conﬁrmed
NS
M 11, F 10 No more information
available












NA 23 6–13 yrs No Yes MR: 7/23 all severe PB PHT CBZ
M 16, F 7 9 14 NE: normal 21/22




NA 22 4–10 yrs No Yes MR: 22/22 VPA
M 9, F 13 4 18 Severe 10/22
Speech difﬁculties
6/22






NAa 62 4–17 yrs No Yes MR: 25/62 PB PHT CBZ No
M 41, F 21 28 34 Severe 12/62 6 24 2 3
Winkler
et al., 2010
Moderate 13/62 PB + PHT 27
NE: NA HN: 100%
Winkler
et al., 2014
Psychiatric: NA Other seizures:
Yes No IF NA
15/34 5/34 3/34 11/34
Abbreviations: AEDs, antiepileptic drugs; CBZ, carbamazepine; F, females; HN, head nodding; IF, increasing frequency; M, males; MR, mental retardation; NA, not available;
NE, neurological exam; No, number of patients; NS, Nodding Syndrome; PB, phenobarbitone; PHT, phenytoin; yrs, years; VPA, valproic acid.
a This study was carried out before the International Scientiﬁc Meeting on Nodding Syndrome, Kampala.
b NS classiﬁcation according to the ‘‘International Scientiﬁc Meeting on Nodding Syndrome’’, Meeting Report, Kampala Uganda, 13 July–1 August 2012.
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19) and showed nodding episodes in clusters during hyperventi-
lation (see two examples in Figs. 3 and 4). In all of them a high-
amplitude, bi- or triphasic slow wave with an inverse phase
reversal over the vertex region was detected. The slow wave was
diffuse but dominant over the frontal regions and lasted 0.5–1.2 s
(patient n. 7), 0.8–1.2 s (patient n. 17), 0.8–1.4 s (patient n. 19). The
slow wave could either be or not be followed by an electrodecre-
mental pattern with diffuse fast activity for 2–4 s (patient n. 7), for
1–2 s (patient n. 17) and for 1 s (patient n. 19). This ictal pattern
was repeated every 3–10 s in almost periodic sequences and the
duration of the cluster was 8 min in patient n. 7 and 3 min in
patients n. 17 and 19. During the cluster, the EEG showed a slowing
background activity with disappearance of alpha rhythms and
activation of interictal abnormalities over the fronto-temporal
regions.
All the subjects displayed intellectual disability, which was
mild in 12 (57%) cases, moderate in seven (33%) cases and severe in
two (almost 10%) cases. The severity of the cognitive deﬁcit did not
always correlate with the presence/absence of epileptiform
abnormalities on the EEG (see Table 2 for details).
All the 21 NS subjects herein described were on antiepileptic
drugs (AEDs). Treatment was adequate in regards to time
(6 months or more on therapy) and dosing in most patients, even
if the actual compliance to therapy was not always clear.
Carbamazepine (CBZ 10 mg/kg/day) was used in 100% of cases,
either in monotherapy in nine subjects (43%) and in association
with Phenobarbitone (PB; 3 mg/kg/day) in nine cases or phenytoin(PHT; 5 mg/kg/day) in three cases. These are the only AEDs
available in South Sudan at this time. None of the patients had
achieved good seizure control, either with regard to nodding
episodes or other types of seizure.
4. Discussion
The present study collected neurophysiological and clinical
data of 21 South Sudanese children affected by NS in order to better
characterize this population and compare these cases with NS
cases observed in Uganda and Tanzania. As a matter of fact, NS has
so far been identiﬁed only in three different locations in Sub-
Saharan Africa: South Sudan, northern Uganda and southern
Tanzania. The main features of the syndrome, as reported in
previously published papers, are summarized in Table 1. The
reports lacking clinical and electrophysiological features were not
included.
In spite of the fact that clinical and neurophysiological data
detected in South Sudan were reported in great detail [2,6,13], to
date no systematic study has been performed. In our study, no
difference in prevalence between males and females was
documented, in line with the International Conference on Nodding
Syndrome (Kampala, 2012) [13]. By contrast, data collected in
Uganda and Tanzania show a slight prevalence of males (55% and
61%, respectively) [8–10,12,15,16]. The age of our children ranged
between 6 and 14 years, and the age at seizure onset was 5–12
years, consistent with reports from Uganda and Tanzania
[8,9,11,14,15].
Table 2

















1 F 11 Rumbek 10 FS 100–800 FT 2–2.5Hz SW
discharges, right T sharp waves
<10% O alpha (8–9Hz) rhythms Probable Mild MR CBZ
2 F 12 Mundri 6 FS with sg 200–500 FCT 1–2.5Hz SW
discharges
30% Diffuse 5–6Hz rhythms; O
alpha (8–9Hz) rhythms
Probable Mild MR PB, CBZ, PHT
3 M 12 Maridi 9 FS 100–200 FCP sharp waves
discharges in theta range
(4–5Hz)
<10% FCP and midline theta rhythms
(4–7Hz); O alpha (8–9Hz)
rhythms
Probable Moderate MR CBZ
4 M 6 Mundri 6 FS 100–200 FC sharpwave discharges
in theta range (4–5Hz)
<10% FCP and midline theta rhythms
(4–5Hz); O unstable theta
(6–7Hz) rhythms
Probable Moderate MR PB, CBZ
5 F 11 Wau 8 FS+GS 100–400 FCT 1.5–2.5Hz SW
discharges
30% Diffuse theta rhythms (4–5Hz);
O unstable theta (6–7Hz)
rhythms
Probable Moderate MR PB, CBZ
6 M 14 Mundri 9 FS Bilateral FT 1.5–2.5Hz spike-
waves and SW discharges
40% Bilateral PTO; Unstable theta
activity
Probable Mild MR CBZ
7 M 12 Yambio 8 GS 100–400 FCT 2–2.5Hz SW
discharges
10% FCP and midline theta rhythms
(4–5Hz); O alpha (10–11Hz)
rhythms
Conﬁrmed Moderate MR PB, CBZ
8 F 9 Mundri 7 FS 100–200 FC sharpwave discharges
in theta range (4–5Hz)
10% Diffuse 5–7Hz rhythms; O
alpha (10–11Hz) rhythms
Probable Moderate MR CBZ
9 M 12 Mundri 9 FS 100–200 FCT 2–3.5Hz SW
discharges
10% FCP and midline theta rhythms
(4–5Hz); O alpha (9–10Hz)
rhythms
Probable Mild MR CBZ
10 F 11 Yambio 10 FS with sg No – Diffuse 5–7Hz rhythms Probable Mild MR PB, CBZ
11 F 14 Juba 12 FS 100–1000 FCT 2–2.5Hz SW
discharges
<5% Diffuse alpha (8–9Hz) rhythms Probable Mild MR CBZ
12 M 12 Juba 11 FS with sg 100–200diffuse 2–3.5Hz SW
discharges; TO sharp wave
activity in theta range (4–6Hz)
– Diffuse alpha (8–9Hz) rhythms Probable Mild MR CBZ, PHT
13 M 9 Yambio 5 FS 100–200 FCT 2–3.5Hz SW
discharges
25% Diffuse 4–7Hz rhythms Conﬁrmed Moderate MR CBZ
14 M 13 Mundri 10 FS+GS Left f basal sharp waves <5% FCP and midline theta rhythms
(4–6Hz); O alpha (9–10Hz)
rhythms
Probable Severe MR PB, CBZ
15 M 12 Yambio 7 FS 100–7‘‘CPT 2–4Hz SW
discharges
15% Diffuse 4–7Hz rhythms; O
alpha (8–9Hz) rhythms
Probable Severe MR CBZ, PHT
16 M 12 Yambio 10 FS+GS (TC) Subcontinuous FCT 1.5–2Hz
SW discharges
85% Diffuse 4–7Hz rhythms Probable Mild MR CBZ, PHT
17 F 11 Juba 5 FS+GS (atonic) 100–7‘‘CPT 2–3.5Hz SW
discharges
<5% Diffuse 4–7Hz rhythms; O
alpha (8–9Hz) rhythms
Conﬁrmed Mild MR PB, CBZ
18 F 14 Juba 9 FS No – O alpha (8–9Hz) rhythms Probable Mild MR CBZ
19 F 14 Mundri 8 FS+GS 100–200 FCT 2–3.5Hz SW
discharges; left T sharp waves
<5% Diffuse 4–7Hz rhythms Conﬁrmed Mild MR PB, CBZ
20 F 13 Juba 12 FS 100–200 CPT 2.5–3.5Hz SW
discharges; left T sharp waves
<10% Diffuse 4–5Hz rhythms Conﬁrmed Mild MR CBZ
21 M 12 Lui 9 FS+SG 100–500 FCT 2–3.5Hz SW
discharges
25% Diffuse 4–5Hz rhythms Conﬁrmed Moderate MR CBZ, PB
Abbreviations: AEDs: antiepileptic drugs; CBZ, carbamazepine; CPT, centro-parieto-temporal; F, female; f, fronto; FC, fronto-central; FCT, fronto-centro-temporal; FCP, fronto-centro-parietal; FS, focal seizures; FT, fronto-temporal;
GS, generalized seizures; M, male; MR, mental retardation; O, occipital; PB, phenobarbitone; PHT, phenytoin; Pt: patient; PTO, parieto-temporo-occipital; sg, secondary generalization; SW, sharp waves; T, temporal; TC, tonic–
clonic; TO, temporo-occipital; yrs, years.





























Fig. 1. Interictal EEG in patient 8. The BA shows diffuse 4–7 Hz rhythms. This abnormal activity is reactive to eye closure (10 Hz occipital rhythms).
Fig. 2. Interictal EEG in patient 16. The BA shows diffuse 5–7 Hz rhythms. High-amplitude 2 Hz spike and wave discharges with intermingled sharp waves are also present. The
epileptiform abnormalities are distributed over the fronto-temporal and midline regions.
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Fig. 3. Ictal EEG in patient 7. One minute and 20 s after starting hyperventilation a cluster of seizures begins: a periodic sequence of four episodes (black arrows) characterized
by a high-amplitude bi- or triphasic slow wave (0.5–1.2 s), dominant over the frontal regions, followed by an electrodecremental pattern with diffuse fast activity for 2–5 s.
During the cluster the background activity is slow and alpha rhythms disappear.
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ingly severe phenotypes and two or more types of seizures [7,8], in
our study this correlation between severity of developmental delay
and seizure occurrence was not observed. As shown in Section 3
and in Table 2, the seizure frequency and abnormal EEG activity
were equally distributed among children with mild, moderate or
severe intellectual disability.
As regards interictal EEG ﬁndings, discharges of variable
duration (from 1 to 10 s) of 2–3.5 Hz spikes and waves, above
all on the bilateral anterior regions (fronto-centro-temporal and
midline) were observed in most of the 21 cases, in line with reports
from Uganda and Tanzania [8,9,11,14,15]. In most patients,
epileptiform abnormalities were activated by hyperventilation.
Moreover, the typical NS diffuse slowing in background activity (4–
7 theta rhythms) was observed in 81% of the cases, consistent with
Sejvar et al.’s study [3]. This EEG feature is considered a genetic
trait [8] and, as underscored by Sejvar et al. [3], it is found in
Lennox–Gastaut syndrome and in some genetic epilepsies such asFig. 4. Ictal EEG in patient 19. At the end of hyperventilation a cluster of seizures begins: a 
over the vertex region is present. The slow wave is diffuse but dominant over the frontal r
wave is repeated every 2000 (ﬁrst three slow wave) and then every 3–5 s in an almost perio
a slowing of BA.Dravet syndrome and myoclonic astatic epilepsy. In 14% of
‘‘Probable NS’’ subjects (3/18 cases), interictal EEG showed no
epileptiform abnormality. This ﬁnding is not an exceptional event
as it was observed both in patients from Tanzania and Uganda by
Winkler et al. [11] and Sejvar et al. [3], too. For this reason,
according to the classiﬁcation criteria of the International
Conference (Kampala, 2012) [13], interictal neurophysiological
data are not considered an essential criterion for the diagnosis of
NS. A puzzling ﬁnding is that patients – despite an interictal EEG
without epileptiform abnormalities – did not only show head
nodding seizures but also other types of seizures.
Seizures during EEG recording were observed in three patients,
showing high-amplitude slow waves repeated in an almost
periodic sequence in all of them. In two patients this activity
was sometimes followed by an electrodecremental pattern with
superimposed fast activity. When associated with clinical ﬁndings
of nodding, these ictal EEG features are typical of epileptic spasm
(ES) (Vigevano et al., 2001) [16]. Recently, many authors havehigh-amplitude, bi- or triphasic slow wave (0.8–1.4 s) with an inverse phase reversal
egions and is rarely followed by diffuse fast activity for 1 s. At the beginning the slow
dic sequence. The duration of the cluster is 3 min. During the cluster the EEG shows
G. de Polo et al. / Seizure 31 (2015) 64–7170described a cryptogenic or symptomatic epileptic encephalopathy
characterized by late-onset variable ES associated with other types
of seizures (mainly atypical absences, tonic spasms), interictal
bilateral slow SW predominant over the fronto-temporal regions
and cognitive deterioration after ES onset (Eisermann et al., 2006;
Ishikawa et al., 2014) [17,18]. The ictal EEG patterns of nodding
seizures have been subject to multiple interpretations so far. Sejvar
et al. [3] found them on EEG and classiﬁed them as atonic seizures;
Winkler [7,8] conceded that this diagnosis was possible even if her
Tanzanian patients showed signs more consistent with a diagnosis
of atypical absences. Tumwine et al. [6] obtained the EEG of 32 NS
patients and were able to record three nodding episodes consistent
with isolated diffuse delta–theta slow waves followed by a brief
and small fast discharge. This paroxysmal activity was observed to
recur in a pseudo-periodical manner. In our study, the recording of
diffuse slow waves corresponding to a spasm and the subsequent
polyspike discharges corresponding to the tonic phase suggest that
nodding seizures are late-onset ES. Clinical (age-related condition)
and EEG (abnormal background activity similar to the well-known
4–7 rhythms) features suggest a genetic origin with possible
different manifestations in the three countries. As evidence of
phenotypic variability, the head nodding seizures during the EEG
were induced by hyperventilation in our patients. It is important to
note that the reﬂex nature of the crisis is demonstrated, although
hyperventilation was never reported as trigger factor [3,7].
Assuming that NS is an epileptic encephalopathy with late-
onset spasms, it would be important to document the evolution of
the ictal and interictal EEGs in these subjects over time because the
only longitudinal study performed so far did not provide any EEG
data (Winkler et al., 2014) [8].
Despite NS is widely recognized as an epileptic encephalopathy,
the level of intellectual disability is extremely variable. Generally
the disease seems to be more severe in Uganda and South Sudan
than in Tanzania [6]. In Tanzania, intellectual disability is reported
in only 40% of the cases, according to the hypothesis that NS is not
rapidly progressive and does not result in severe encephalopathy
in this region [7]. All our patients presented with intellectual
disability, which was mild in 12 (57%) cases, moderate in seven
(33%) cases and severe in two (almost 10%) cases. This is a peculiar
ﬁnding since published studies did not report the presence of
intellectual disability in all NS patients [4]. It could be due to the
ongoing epilepsy or might be a related feature arising from a
common pathophysiology [13]. Although it is well known that the
severity of the disease is associated with more severe EEG ﬁndings
with progressive worsening and loss of normal cerebral electrical
architecture [2], we found no correlation between: disease
duration and percentage of abnormal EEG activity; disease
duration and severity of intellectual disability; and percentage
of abnormal EEG activity and severity of intellectual disability. It
may therefore be assumed that the variability in the clinical
evolution of NS depends on unknown factors (genetic susceptibili-
ty, food effects or response to AEDs).
All our patients were on AEDs but none of them achieved good
seizure control with the available drugs. On the contrary, based on
the speciﬁc interictal and ictal EEG patterns, clinical manifesta-
tions, and on the experience of other researchers, valproic acid
would seem to be the ﬁrst-choice antiepileptic drug. In Idro et al.’s
study [15], valproate led to an almost 60% reduction in total
seizures, including clusters of nodding. Moreover, should the
diagnosis of ES be conﬁrmed, many other treatments could be tried
such as pyridoxine, vigabatrin and steroids.
5. Study limitations
First, a standardized test was not available. Intellectual
disability was rated according to the ability to perform daily lifeactivities. Furthermore, serial follow-up data on cognitive im-
pairment were not available and an intellectual regression was
speculated only based on the patient’s medical history.
Second, no screening test for infectious or toxin markers was
performed.
6. Conclusion
This study conﬁrms that NS is an encephalopathy and
intellectual disabilities do seem to be partially independent of
seizure frequency or pathological activity on the EEG in some
cases, even if multiple possible confounders (including inadequacy
of treatment, lag time to treatment, age at onset, and the small
sample size upon which this conclusion was drawn) may play a
role. However, our assumption is that NS is a form of epileptic
encephalopathy with late-onset ES as possible genetic background.
In point of fact, consistent with Winkler et al. [7,8] our data showed
a positive family history of epilepsy (both generalized tonic–clonic
and head nodding seizures) and a peculiar EEG pattern. Further-
more, environmental factors such as infectious may play a role
[7,8]. Nevertheless, the natural history of NS is not well-known so
far and accurate clinical, longitudinal video-EEG, and genetic
prospective research are needed to verify our causative hypothesis.
NS in South Sudan presents with clinical and neurophysiologi-
cal features which are similar to those described in northern
Uganda and more severe than in Tanzania.
For a more accurate classiﬁcation of this syndrome, follow-up
studies are needed in order to ensure appropriate monitoring of
the disease for a number of years since its onset. Specialist centers
in the diagnosis and treatment of epilepsy such as ‘‘Usratuna’’
could become Reference Centers for the syndrome by contributing
to the description of the natural history of the disease as well as
providing care to the affected children and their families. By
‘‘providing care’’ to children with NS we mean to help their families
to overcome the severe stigma of social exclusion which is often
associated with the disease. As proposed by the WHO, the key
professionals best suited to perform this tricky work are
Community-based Rehabilitation (CBR) workers. In fact, the CBR
approach is a capable model in that it ensures surveillance, case
detection, support to family members at household level and
promotion of case management at health center level through
referral systems and constant follow-up of the cases. If properly
trained, CBR workers can work closely with neurologists and
clinical ofﬁcers and provide valuable support for patients as well as
help developing a better understanding of a disease which remains
a mystery under many aspects.
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